UPLOAD Filing
Humacyte, Inc.
Date: Sept. 17, 2025 · CIK: 0001818382 · Accession: 0000000000-25-010132
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290231
Letter
Re: Humacyte, Inc. Registration Statement on Form S-3 Filed September 12, 2025 File No. 333-290231 Dear Dale Sander:
September 17, 2025
Dale Sander Chief Financial Officer Humacyte, Inc. 2525 East North Carolina Highway 54 Durham, NC 27713
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Kerry S. Burke
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> September 17, 2025 Dale Sander Chief Financial Officer Humacyte, Inc. 2525 East North Carolina Highway 54 Durham, NC 27713 Re: Humacyte, Inc. Registration Statement on Form S-3 Filed September 12, 2025 File No. 333-290231 Dear Dale Sander: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Kerry S. Burke </TEXT> </DOCUMENT>